WCN24-752 CONCOMITANT SPARSENTAN AND SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS (SGLT2is) IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN) IN THE PROTECT OPEN-LABEL EXTENSION (OLE)

Saved in:
Bibliographic Details
Main Authors: Radko Komers, Laura Kooienga, Robert Malecki, Alex Mercer, Nuhira Ahmed Masthan Ahmed, Priscila Preciado
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Kidney International Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024924003796
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850127840797786112
author Radko Komers
Laura Kooienga
Robert Malecki
Alex Mercer
Nuhira Ahmed Masthan Ahmed
Priscila Preciado
author_facet Radko Komers
Laura Kooienga
Robert Malecki
Alex Mercer
Nuhira Ahmed Masthan Ahmed
Priscila Preciado
author_sort Radko Komers
collection DOAJ
format Article
id doaj-art-b73a62c93abf48b198ffb5e767ffb5fc
institution OA Journals
issn 2468-0249
language English
publishDate 2024-04-01
publisher Elsevier
record_format Article
series Kidney International Reports
spelling doaj-art-b73a62c93abf48b198ffb5e767ffb5fc2025-08-20T02:33:34ZengElsevierKidney International Reports2468-02492024-04-0194S140S14110.1016/j.ekir.2024.02.290WCN24-752 CONCOMITANT SPARSENTAN AND SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS (SGLT2is) IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN) IN THE PROTECT OPEN-LABEL EXTENSION (OLE)Radko Komers0Laura Kooienga1Robert Malecki2Alex Mercer3Nuhira Ahmed Masthan Ahmed4Priscila Preciado5San Diego, Clinical Development, Nephrology, United StatesResearch Division, Colorado Kidney Care, DenverDepartment of Nephrology, Międzyleski Specialist Hospital, WarsawN/A, JAMCO Pharma Consulting, StockholmBiostatistics, Travere Therapeutics, Inc., San DiegoClinical Development, Nephrology, Travere Therapeutics, Inc., San Diegohttp://www.sciencedirect.com/science/article/pii/S2468024924003796
spellingShingle Radko Komers
Laura Kooienga
Robert Malecki
Alex Mercer
Nuhira Ahmed Masthan Ahmed
Priscila Preciado
WCN24-752 CONCOMITANT SPARSENTAN AND SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS (SGLT2is) IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN) IN THE PROTECT OPEN-LABEL EXTENSION (OLE)
Kidney International Reports
title WCN24-752 CONCOMITANT SPARSENTAN AND SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS (SGLT2is) IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN) IN THE PROTECT OPEN-LABEL EXTENSION (OLE)
title_full WCN24-752 CONCOMITANT SPARSENTAN AND SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS (SGLT2is) IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN) IN THE PROTECT OPEN-LABEL EXTENSION (OLE)
title_fullStr WCN24-752 CONCOMITANT SPARSENTAN AND SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS (SGLT2is) IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN) IN THE PROTECT OPEN-LABEL EXTENSION (OLE)
title_full_unstemmed WCN24-752 CONCOMITANT SPARSENTAN AND SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS (SGLT2is) IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN) IN THE PROTECT OPEN-LABEL EXTENSION (OLE)
title_short WCN24-752 CONCOMITANT SPARSENTAN AND SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS (SGLT2is) IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN) IN THE PROTECT OPEN-LABEL EXTENSION (OLE)
title_sort wcn24 752 concomitant sparsentan and sodium glucose cotransporter 2 inhibitors sglt2is in patients with immunoglobulin a nephropathy igan in the protect open label extension ole
url http://www.sciencedirect.com/science/article/pii/S2468024924003796
work_keys_str_mv AT radkokomers wcn24752concomitantsparsentanandsodiumglucosecotransporter2inhibitorssglt2isinpatientswithimmunoglobulinanephropathyiganintheprotectopenlabelextensionole
AT laurakooienga wcn24752concomitantsparsentanandsodiumglucosecotransporter2inhibitorssglt2isinpatientswithimmunoglobulinanephropathyiganintheprotectopenlabelextensionole
AT robertmalecki wcn24752concomitantsparsentanandsodiumglucosecotransporter2inhibitorssglt2isinpatientswithimmunoglobulinanephropathyiganintheprotectopenlabelextensionole
AT alexmercer wcn24752concomitantsparsentanandsodiumglucosecotransporter2inhibitorssglt2isinpatientswithimmunoglobulinanephropathyiganintheprotectopenlabelextensionole
AT nuhiraahmedmasthanahmed wcn24752concomitantsparsentanandsodiumglucosecotransporter2inhibitorssglt2isinpatientswithimmunoglobulinanephropathyiganintheprotectopenlabelextensionole
AT priscilapreciado wcn24752concomitantsparsentanandsodiumglucosecotransporter2inhibitorssglt2isinpatientswithimmunoglobulinanephropathyiganintheprotectopenlabelextensionole